BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5399 related articles for article (PubMed ID: 524978)

  • 1. [Accuracy of the clinical diagnosis in malignant melanomas].
    Hühn W; Friedrich HJ; Ruppel R; Hundeiker M
    Z Hautkr; 1979 Oct; 54(20):914-20. PubMed ID: 524978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric melanoma: a single-institution experience of 150 patients.
    Aldrink JH; Selim MA; Diesen DL; Johnson J; Pruitt SK; Tyler DS; Seigler HF
    J Pediatr Surg; 2009 Aug; 44(8):1514-21. PubMed ID: 19635298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
    Søndergaard K
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymphadenectomy for staging patients with intermediate-level melanoma.
    Smart KR; Cahoon BW; Dale PS
    Am Surg; 2000 Mar; 66(3):280-3. PubMed ID: 10759200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic progress in malignant melanomas by high-resolution real-time sonography].
    Kraus W; Nake-Elias A; Schramm P
    Hautarzt; 1985 Jul; 36(7):386-92. PubMed ID: 3899995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6 year prospective analysis of the diagnosis of malignant melanoma in a pigmented-lesion clinic: even the experts miss malignant melanomas, but not often.
    Duff CG; Melsom D; Rigby HS; Kenealy JM; Townsend PL
    Br J Plast Surg; 2001 Jun; 54(4):317-21. PubMed ID: 11355986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between melanoma thickness and time to diagnosis in a large population-based study.
    Baade PD; English DR; Youl PH; McPherson M; Elwood JM; Aitken JF
    Arch Dermatol; 2006 Nov; 142(11):1422-7. PubMed ID: 17116832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.
    Garbe C; Leiter U; Ellwanger U; Blaheta HJ; Meier F; Rassner G; Schittek B
    Cancer; 2003 Apr; 97(7):1737-45. PubMed ID: 12655531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical diagnosis of early malignant melanomas].
    Schmoeckel C; Wagner-Grösser G; Braun-Falco O
    Hautarzt; 1985 Oct; 36(10):558-62. PubMed ID: 4066315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 270.